MedPlus Health Services (MEDPLUS) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
9 Feb, 2026Executive summary
Operates 4,444 pharmacy outlets across 650+ cities in 10 states, with 469 net new stores added in the last 12 months and 37 net additions in Q1 FY25.
Board approved unaudited standalone and consolidated financial results for Q1 FY25, with statutory auditors issuing an unmodified limited review report.
Maintained leadership in 4 of the top 6 Indian cities and continued cluster-based expansion for deeper market penetration.
Private-label products now account for 15.8% of total revenue, up from 7.9% year-over-year, reflecting a strategic focus on own brands.
Q1 is seasonally weak due to lower demand and customer vacations, but management maintains full-year growth and margin guidance.
Financial highlights
Consolidated revenue for Q1 FY25 was INR 14,888 million, up 15.9% year-over-year and flat sequentially.
Pharmacy operations contributed 99% of revenue, with pharmacy GMV up 24% year-over-year and net revenue up 15.3%.
Operating EBITDA was INR 435 million (2.9% margin), and PAT reached INR 143.4 million, up 281.2% year-over-year.
Diagnostic revenue grew to INR 242 million from INR 139 million year-over-year, with segment EBITDA turning positive at INR 3.3 million, though segment loss was reported in statutory filings.
Store-level EBITDA margin for stores older than 12 months was 9.3%; for stores older than 24 months, 9.7%.
Outlook and guidance
Management reiterates guidance of 20%+ reported revenue growth and maintaining Q4-level margins for FY25.
Store addition target for FY25 remains at 600, with a possible increase in closures due to network optimization.
Plans to further grow in existing clusters, develop new ones, and expand private label offerings in pharma and FMCG.
Private-label share expected to continue rising, with management targeting further growth and providing more guidance in coming quarters.
Board scheduled the 18th Annual General Meeting for September 26, 2024, and set up e-voting procedures.
Latest events from MedPlus Health Services
- Q2 FY25 revenue up 11.9% YoY, gross margin rises, PAT surges 166%, and store network expands.MEDPLUS
Q2 24/253 Feb 2026 - Q3 FY26 revenue up 15.7% YoY, margin gains, and store growth drive profit and efficiency.MEDPLUS
Q3 25/262 Feb 2026 - Q2 FY26 revenue up 6.5% YoY, net profit up 43.4%, 117 net new stores, private label at 21.5%.MEDPLUS
Q2 25/2619 Dec 2025 - Q3 FY25 revenue up 8.3% YoY, net profit up 234.7%, and margin at 25.0%.MEDPLUS
Q3 24/2519 Dec 2025 - Q1 FY26 revenue up 3.6% YoY, gross margin at 26.1%, and private label share at 20.4%.MEDPLUS
Q1 25/2619 Dec 2025 - FY25 revenue up 9.1% and PAT up 129%, with 305 new stores, higher margin, and strong cash flow.MEDPLUS
Q4 24/2519 Dec 2025